Core Insights - The recent publicity surrounding the chairman of a pharmaceutical company promoting its product, ergothioneine capsules, led to a significant 20% increase in the stock price of its subsidiary, Chuaning Bio [1] - Despite initial market excitement, the price of ergothioneine has drastically decreased from 300,000 yuan per kilogram to below 10,000 yuan due to advancements in synthetic biology and increased competition [1][2] - The company Jinsan Bio has decided to fully commit to promoting ergothioneine, aiming to establish itself as an industry leader by actively creating market demand rather than waiting for trends to develop [2][4] Company Strategy - Jinsan Bio's founder, Ding Wei, emphasizes the importance of innovation and market leadership, stating that to become an industry leader, one must pave new paths and help generate market interest [2][8] - The company has set ambitious sales targets, aiming for a gross merchandise volume (GMV) of 300 million yuan in 2023 and 500 million yuan in 2024, with a monthly GMV exceeding 30 million yuan by 2025 [2][3] - Jinsan Bio has successfully completed a Pre-A round of financing exceeding 100 million yuan, with investments from various funds, indicating strong investor confidence in its business model [2] Product Development and Marketing - Jinsan Bio has developed a range of products including skincare serums, oral capsules, and eye drops, focusing on the health benefits of ergothioneine [10] - The company employs a dual strategy of B2B and B2C, selling raw materials while also marketing consumer products, which has proven effective due to the team's background in consumer goods [4][7] - The marketing strategy includes leveraging online sales channels such as JD, Tmall, and Douyin, with a significant portion of sales coming from live-streaming and private domain traffic [11] Research and Clinical Trials - Jinsan Bio is conducting investigator-initiated trials (IIT) to validate the health benefits of ergothioneine, focusing on its effects on liver function and eye health [5][6] - The decision to pursue IIT is seen as a unique approach in the dietary supplement industry, providing scientific evidence to support the efficacy of their products [6] Industry Context - The decline in raw material prices has led many investors to be cautious about ergothioneine, but Jinsan Bio's proactive approach aims to change this perception and stimulate market growth [2][4] - The company positions itself as a leader in the ergothioneine niche, aiming to create a robust market presence and consumer awareness [8][15]

付才力提起了新加坡项目团队第一次来常考察的情景：政府和专家团队全程陪同，并给予了专业的指导和建议。"政府的高度重视，让我们在接洽过程中感 到特别温暖。尤其是许多项目团队落地这里时积累的经验，他们克服困难、实现项目成果转化的过程，都对我们的项目有借鉴意义。"付才力介绍，创新中 心将瞄准食品生物合成领域，通过中试放大技术赋能初创企业，未来将依托常州产业生态加速技术转化与市场拓展。 加速构建千亿级合成生物产业集群，常州向世界递出了"中国生物制造"新名片。5月13日，一场引领生物经济未来的重要大会——合成生物技术成果路演暨 国家重点研发计划"合成生物学"重点专项综合绩效评价会在常州启幕。作为国内合成生物产业发展的前沿阵地，常州高新区借此次活动，以"成果转化+项目 评价"双轮驱动，加速构建具有全球影响力的合成生物创新高地。 当天，常州高新区"以投带引"再结硕果：常州众库安糖管家项目、山东大学酶促基因合成项目、动物营养及育种项目、新加坡国立大学健康食品创新中心4 个项目签约落户，合成生物再添新力量。 "常州，我们慕名而来！"谈及项目落子，新加坡国立大学健康食品创新中心项目代表付才力激动不已，"常州的区位优势、港口资源以及 ...

天津：加快推进产业焕新 金十数据5月17日讯，天津市人民政府发布关于印发天津市推动科技创新和产业创新深度融合工作方案 （2025—2027年）的通知。其中提到 加快推进产业焕新。支持化工、冶金、轻工等产业开展生产技术 改造、核心装备升级、高端产品研发，加快高端化、智能化、绿色化转型，推动传统产业升级焕新。聚 焦人工智能、生物医药、新能源、新材料等重点产业，强化研发与制造双向联动，加快技术产品迭代升 级，促进企业集聚协同、产业规模化发展，建设一批特色产业集群，培育壮大战略性新兴产业。聚焦合 成生物、脑机接口、商业航天等领域开展前沿技术探索，以场景应用驱动研发转化，加速培育未来产 业。 （天津市政府官网） ...

金 融 期 货 研 究 | | | 毛磊 | | | 投资咨询从业资格号：Z0011222 | | maolei@gtht.com | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 【期指期现数据跟踪】 | | | | | | | | | 期指数据 | | | | | | | | | | | 收盘价 | 涨跌幅% | 基 差 | 成交额-亿 | 成交量 | 变 动 | 持仓量 | 变 动 | | 沪深300 | 3907.2 | ↓0.91 | | 2414.6 | | | | | | IF2505 | 3908.2 | ↓0.74 | 1 | 239.3 | 20365 | ↓13325 | 19193 | ↓11402 | | IF2506 | 3872.8 | ↓0.74 | -34.4 | 698.1 | 59965 | ↓21992 | 153318 | ↓11284 | | IF2509 | 3808.2 | ↓0.67 | -99 | 181.5 | 15855 | ↓2926 | 65235 | ↓244 | | I ...

Market Overview - On May 15, the A-share market experienced fluctuations, with the ChiNext index leading the decline. The Shanghai Composite Index fell by 0.68% to 3380.82 points, the Shenzhen Component Index dropped by 1.62% to 10186.45 points, and the ChiNext Index decreased by 1.91% to 2043.25 points. The total trading volume in the Shanghai and Shenzhen markets was 1.15 trillion yuan, a decrease of 164.3 billion yuan compared to the previous trading day [1][2]. Sector Performance - The market showed a mixed performance with over 3800 stocks declining. Notable gainers included synthetic biology stocks, food consumption stocks, and ST stocks, while computing power concept stocks underwent adjustments. The sectors with the highest gains were synthetic biology, food, ST stocks, and ports, while software development, cross-border payment, computing power, and Hongmeng concept stocks faced the largest declines [1]. International Market - In the U.S. stock market on May 15, the Dow Jones Industrial Average rose by 271.69 points (0.65%) to 42322.75 points, and the S&P 500 increased by 24.35 points (0.41%) to 5916.93 points. However, the Nasdaq Composite fell by 34.49 points (0.18%) to 19112.32 points [2][4]. - European stock indices also saw gains, with the FTSE 100 up by 48.74 points (0.57%) to 8633.75 points, the CAC 40 rising by 16.68 points (0.21%) to 7853.47 points, and the DAX increasing by 168.58 points (0.72%) to 23695.59 points [3]. Commodity Prices - International oil prices declined on May 15, with light crude oil futures for June delivery falling by $1.53 to $61.62 per barrel (a decrease of 2.42%), and Brent crude for July delivery dropping by $1.56 to $64.53 per barrel (a decrease of 2.36%) [3]. Policy Developments - The Central Committee of the Communist Party and the State Council issued an opinion on promoting urban renewal, emphasizing sustainable urban development and the establishment of a comprehensive urban renewal model [5]. - The People's Bank of China and other departments emphasized full support for technological innovation, advocating for early, small, long-term, and hard technology investments [6]. Legal and Regulatory Updates - The Supreme Court and the China Securities Regulatory Commission announced measures to combat market disruptions caused by false information and illegal activities, emphasizing the protection of market integrity [7][8]. - The People's Bank of China plans to enhance the "Swap Connect" product offerings, extending interest rate swap contracts to 30 years to meet diverse market needs [9]. Trade Relations - The Ministry of Commerce expressed openness to resolving trade concerns with the U.S. through dialogue and indicated plans to release updates on U.S.-China trade negotiations [10]. - The Ministry of Commerce criticized the U.S. for imposing stricter restrictions on Chinese chips, labeling it as unilateral and protectionist behavior that harms global supply chains [11]. Investment Insights - According to China International Capital Corporation, the U.S. market is experiencing a "triple kill" scenario in stocks, bonds, and currencies, indicating a significant change in the inflation environment and dollar cycle [14]. - Citic Securities noted that the growth rate of social financing in April continued to rise, driven by low base effects from the previous year, but cautioned about the need for further observation regarding financing demand [15].

Market Overview - The market experienced a significant decline with a large reduction in trading volume, as the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index fell by 0.68%, 1.62%, and 1.91% respectively, with over 3,800 stocks declining and only about 1,400 stocks rising [3] - The total trading volume for the two markets was only 1.15 trillion [3] Sector Performance - The "Ergothioneine" concept stocks surged, with companies like Bavi Co., Chuaning Bio, and Tuoxin Pharmaceutical hitting the daily limit up [6] - The cosmetics and synthetic biology sectors also saw collective gains, with several stocks reaching their daily limit [7] - The textile and dyeing sectors performed well, with stocks like Yingfeng Co. and Suzhou Longjie achieving multiple consecutive gains [3] - Other sectors such as food, beverages, and agricultural planting showed localized strength, while cross-border payment, computing power, fintech, and magnetic levitation compressor sectors faced significant declines [3] Ergothioneine Concept - The emergence of the "Ergothioneine" concept was sudden, reportedly driven by a viral post claiming a 60-fold increase in sales [8] - A week prior, media coverage of a promotional video featuring the chairman of Kelun Pharmaceutical, showcasing his physique at 75 years old, contributed to the hype [8][9] - Despite the surge in related stocks, Kelun Pharmaceutical itself only saw a modest increase of less than 3% [10] - The phenomenon is characterized as a "manufactured concept," similar to previous trends that have emerged in the market [11][12] Shipping Sector - Following two days of significant gains, media reports highlighted a "90-day window period" leading to a surge in shipping demand, with some companies experiencing price increases of 20% [17] - Stocks in the shipping and port sectors initially opened strong but later retreated, with overall gains of 0.2% and 0.51% respectively [19] Technology Sector - Hongjing Technology announced a contract worth 563 million for server and computing power services, which is seen as positive news [21] - However, the stock experienced a decline of over 9% following a significant prior increase, indicating market skepticism [21] Focus on Strong Stocks - The market saw a widespread decline, but certain "stronghold stocks" continued to perform well, with notable gains in stocks like Yuzhisanxia and Huafang Co. [24] - The market behavior reflects extreme volatility, with some stocks experiencing significant gains while others struggle [24]

合成生物概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 301301 | 川宁生 物 | 20.03 | 23.97 | 55836.64 | 28.09 | | 002626 | 金达威 | 9.99 | 4.82 | 15531.49 | 29.36 | | 600223 | 福瑞达 | 10.04 | 3.47 | 11105.16 | 40.03 | | 002422 | 科伦药 业 | 2.98 | 1.93 | 10625.04 | 12.06 | | 301089 | 拓新药 业 | 20.02 | 17.97 | 8736.29 | 18.23 | | 300132 | 青松股 份 | 20.08 | 21.04 | 6854.51 | 10.61 | | 300189 | 神农种 | 3.50 | 24.42 | 5681.73 | 6.00 | | | 业 | | | | | 截至5月 ...

Market Overview - The Shanghai Composite Index closed at 3380.82 points, down 0.68%, with a trading volume of 461.29 billion yuan [1] - The Shenzhen Component Index closed at 10186.45 points, down 1.62%, with a trading volume of 691.11 billion yuan [1] - The ChiNext Index closed at 2043.25 points, down 1.91%, with a trading volume of 315.82 billion yuan [1] - The total trading volume of both markets was 1152.41 billion yuan, a decrease of 164.34 billion yuan compared to the previous trading day [1] Sector Performance - Strong sectors included beauty care, coal, and agriculture, while sectors like computing, communication, and electronics saw significant declines [2] - The beauty care and synthetic biology concepts showed active performance, with 1276 stocks rising and 3726 stocks falling [2] - The number of stocks hitting the daily limit up was 77, while 12 stocks hit the limit down [2] Individual Stock Highlights - *ST Yazhen recorded 8 consecutive limit-up days, the highest among stocks [5] - The stock with the highest limit-up order volume was Ningbo Shipping, with 135 million shares [2] - 11 stocks had limit-up order amounts exceeding 100 million yuan, with Ningbo Shipping leading at 549 million yuan [3] Fund Flow Analysis - The net outflow of main funds from the Shanghai and Shenzhen markets was 53.115 billion yuan, with the ChiNext seeing a net outflow of 18.545 billion yuan [6] - The pharmaceutical sector saw the highest net inflow of main funds, totaling 704 million yuan, followed by beauty care and coal [6] - 29 stocks received net inflows exceeding 100 million yuan, with Chuaning Biological leading at 563 million yuan [9][10] Institutional Activity - Institutions had a net sell of approximately 664 million yuan, with the highest net buy in Aerospace Nanhu at about 30.1 million yuan [15][16] - The stock with the highest net sell by institutions was Youfu Co., with a net outflow of 146 million yuan [15][17]

为了促进合成生物技术创新和产业化应用，推动生物制造加快发展，打造全球合成生物创新策源地和产业集聚地，5月12日，深圳市人大常委会发布关于 《深圳经济特区促进合成生物产业创新发展若干规定（草案）》公开征求意见的公告，征求意见截止日期为6月13日。 中共青岛市委科技委员会在4月份印发了《青岛市合成生物创新发展行动方案（2025—2027年）》（以下简称《方案》）。《方案》提出，到2027年，力争 突破关键技术不少于30项，形成国际先进水平创新成果不少于5项，新增生物制造领域各级创新平台不少于5个，打造标志性产业化项目不少于10项，培育一 批高成长企业，瞪羚、专精特新、科技领军企业总计突破30家，新增具有国际影响力的顶尖科学家团队不少于2个。 "作为前沿科技领域之一，合成生物对于推动经济高质量发展和提升国际竞争力具有重要意义。"盘古智库（北京）信息咨询有限公司高级研究员余丰慧对 《证券日报》记者说道，"通过政策扶持，可以加速科研成果的转化应用，吸引更多的投资者进入这一领域，并促进产业链上下游的合作与发展，同时也为 解决环境、资源等社会问题提供新的思路和技术手段。" 据华安证券（600909）研报，合成生物学是一门基 ...

Market Overview - On May 15, the market experienced fluctuations with the ChiNext Index leading the decline. The Shanghai Composite Index fell by 0.68%, the Shenzhen Component Index dropped by 1.62%, and the ChiNext Index decreased by 1.91% [1] - The overall market saw 1,417 stocks rise, with 76 hitting the daily limit, while 3,916 stocks fell, with 13 hitting the lower limit. The total trading volume in A-shares was 1.19 trillion yuan, a decrease of 159.47 billion yuan from the previous trading day [1] Sector Performance - The synthetic biology sector saw significant gains, with stocks like Jindawei hitting the daily limit. Consumer stocks, including Xiwang Food, also rebounded, while the ST sector strengthened with over 20 stocks hitting the daily limit [1] - The beauty care, NMN concept, synthetic biology, pet economy, China-South Korea Free Trade Zone, dairy, planting and forestry, vitamins, and beverage manufacturing sectors had notable increases, with beauty care rising by 6.46% and NMN concept by 2.07% [4] - Conversely, sectors such as Huawei Pangu, DRG/DIP, Huawei Ascend, and digital currency saw declines, with Huawei Pangu down by 3.76% [5] Notable Stocks - New hotspots emerged in the A-share market, particularly in the ergotamine concept, with stocks like Chuaning Biological and Ruoyuchen hitting the daily limit. Chuaning Biological saw a rise of 20.03% [6] - The precious metals sector faced a downturn, with gold prices dropping from nearly $3,200 per ounce to $3,120 per ounce, marking a decline of 1.38% [9][11] - The precious metals index fell by 1.64%, with companies like Shengda Resources and Hunan Silver experiencing declines of over 2% [11] Rare Earth Sector - The rare earth sector showed strength, with companies like Jingyuntong and Jiuling Technology hitting the daily limit and others like Shenghe Resources rising over 6% [14] - Shenghe Resources announced plans to acquire Peak Rare Earths Limited for 158 million Australian dollars to enhance its resource base [14] - China Rare Earths is actively working with the China Rare Earth Group to address industry competition and is considering mergers and acquisitions [15]